The newly launched memecoin "OZMPC," inspired by the diabetes drug Ozempic, has raised concerns on Coinbase's blockchain, Base, due to its thin liquidity. The token, unauthorized by the drug's manufacturer, Novo Nordisk, has seen a sharp decline from its peak, prompting warnings from CoinGecko Terminal about potential price disparities across exchanges. With a negligible market cap, the creator's 70% tax on buy transactions has drained early investments, leaving the project's future in jeopardy.
Unauthorized Ozempic Meme Coin Emerges on Coinbase's Blockchain, Raising Red Flags
London, United Kingdom - A meme coin bearing the acronym "OZMPC," bearing resemblance to the popular blood sugar medication Ozempic, has surfaced on Coinbase's blockchain, Base. Despite its association with the widely prescribed drug, the meme coin has no affiliation with the pharmaceutical manufacturer, Novo Nordisk.
Concerns over the coin's legitimacy arose promptly, with CoinGecko's Terminal issuing warnings of its precarious liquidity across trading pairs within an hour of its launch. The token's abbreviation, OZMPC, mirrors that of Ozempic, a registered trademark of Novo Nordisk. However, the Danish healthcare conglomerate has not provided any comment regarding the unauthorized use of its product's name.
OZMPC's launch was accompanied by a hefty 70% tax on buy transactions, a tactic that swiftly depleted the majority of initial investments. The token's value has plummeted by 65% from its peak, now trading below one penny.
The coin's negligible market capitalization has led to significant volatility, with Gecko Terminal cautioning potential buyers that its lack of liquidity could result in substantial price disparities across exchanges. Notably, OZMPC lacks any bids on most global crypto exchanges.
At the time of writing, an estimated $5 million had been extracted from the Ozempic meme coin through smart contract taxes, a sum exceeding its current market value.
OZMPC's emergence exemplifies the rampant speculation within the meme coin market, where malicious taxation practices target early buyers who often conduct insufficient due diligence. The coin's unauthorized use of a patented drug name also raises legal concerns for its creators.
This trend mirrors the "initial coin offering" (ICO) craze of early 2018, wherein projects raised vast sums without disclosing concrete plans or providing adequate safeguards for investors. However, unlike ICOs, meme coin founders now operate with even less transparency, often neglecting to create whitepapers or provide any roadmap for the use of investors' funds.
